Strong Heart and Vascular Center
Our Technology
At Strong Health, using the best technology for the right situations
is fundamental to our mission.
We have emerged as a leader in medical excellence by being the
first in the region to learn and use the most promising new procedures
and equipment.
-
We are one of only one hundred United States hospitals currently offering coronary brachytherapy, a treatment to prevent stented heart vessels from re-occluding.
-
The FDA approved an entirely new approach to relieving the symptoms of heart failure -- the Medtronic In-Synch Bi-ventricular Pacemaker for cardiac resynchronization (re-coordinating cardiac muscle function) in August of 2001. We verified its efficacy and have successfully used it to improve the quality of life for many patients with significant to severe heart failure.
-
The Strong Health Transplant team is in the vanguard of using ventricular assist devices (pumps designed to aid a person with a failing left ventricle where IV medication is no longer effective). The group also provides assistance to surrounding hospitals in developing and implementing ventricular assist programs.
-
With the exception of Columbia-Presbyterian Medical Center in New York City, Golisano Children's Hospital at Strong is the only site in New York, Ohio, and Pennsylvania that has a new device called an Amplatzer Duct Occluder . This device allows a cardiologist to close abnormal blood vessels without surgery, a scar, or an extended hospital stay or recovery time.
- Our adoption of the latest in minimally invasive bypass surgery and off-pump heart surgery are making heart surgery less invasive and safer each year. We are proud to offer a degree of specialized care few hospitals can match.
 |
Rapid developments in new health care technology have become almost daily events. But, 'the newest' isn't always 'the best,' and the latest technical advancement isn't always the right answer for every patient. Our research arm moves us to the forefront of investigation so we can select the breakthroughs with the greatest potential to change lives for the better. Then, our participation in clinical trials further refines our knowledge of how a new therapy works, patients it is most likely to benefit, and ways to improve it." Bradford
C. Berk, M.D., Ph.D. |